Valor Intrínseco del S&P y Nasdaq Contáctenos

Alvotech ALVOW NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IS • USD

SharesGrow Score
57/100
2/6 Pass
SharesGrow Intrinsic Value
$76.24
+27128.6%

Alvotech (ALVOW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Los analistas estiman Beneficio por acción (EPS) de $-0.13 y ingresos de $0.45B para el próximo año fiscal.

Historial de Beneficio por acción (EPS): 2024: real $-0.87 vs est $-0.13 (no alcanzó -593.3%). 2025: real $0.10 vs est $-0.08 (superó +223.1%). Precisión del analista: 0%.

Estimaciones de BPA — ALVOW

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.87 vs Est –$0.13 ▼ 85.6% off
2025 Actual $0.10 vs Est –$0.08 ▲ 181.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

Estimaciones de Ingresos — ALVOW

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.490B vs Est $0.454B ▲ 7.2% off
2025 Actual $0.586B vs Est $0.581B ▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje